The complex pharmaceutical supply chain is ripe for disruption from all angles. Here's how startups are leveraging tech to simplify the process of prescribing and delivering medication.
The drug supply chain is complicated, opaque, and overcrowded, involving a host of intermediaries that stand between drug manufacturers and the patients they aim to serve.
These intermediaries — which include wholesalers, pharmacy benefit managers (PBMs), insurers, and pharmacies — capture $41 of every $100 spent on drugs in a retail pharmacy, and have a combined market cap of almost three-quarters of a trillion dollars.
In this complex system, startups are leveraging technology to upend the incumbents at all levels of the supply chain, from prescription to last-mile delivery.
Using CB Insights data, we rounded up 40+ startups leveraging technology to simplify and improve the pharmaceutical supply chain.
This market map consists of private, active companies and is not meant to be exhaustive of the space. Categories are not mutually exclusive, and companies are mapped according to primary use case.
Please click to enlarge.